The Distributions of HCV Genotypes in Hemodialysis Patients in Iraq

سال انتشار: 1398
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 184

فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJMM-13-4_004

تاریخ نمایه سازی: 10 اسفند 1399

چکیده مقاله:

Objectives: The aim of this report was to investigate the genotypes of HCV in patients on regular hemodialysis in Iraq. Methods: A cross sectional study was conducted to investigate the genotypes of HCV in patients on regular hemodialysis in 7 centers across Iraq. 255 subjects with positive anti-HCV antibodies were recruited in this study. Results: To confirm the positivity, RTPCR was performed. Amongst all samples, 31% (79/255) was positive by RTPCR. Then, we genotyped all the RTPCR positive samples, it was found that 39/79 (49.4 %) of our samples were typed as HCV genotype 1 including 26 samples (66.7%) as HCV 1a and 13 samples (33.3%) as HCV 1b. HCV genotype 4 was found in 34/79 (43%) of the samples while 6/79 (7.6%) of the samples typed as HCV 3 Conclusions: HCV genotype 1 was the most prevalent genotype followed by genotype 4. Further population-based study is required to investigate the prevalence of HCV genotypes.

نویسندگان

Nawfal Hussein

College of Medicine, University of Zakho, Zakho, Kurdistan region, Iraq

Eman Sh Al-Obeidy

Dialysis Center, Baghdad Medical cities, Baghdad, Iraq

Ibrahim Naqid

College of Medicine, University of Zakho, Zakho, Kurdistan region, Iraq

Kais H Abd

Duhok Renal Dialysis Center, Duhok, Kurdistan Region, Iraq

Shakir Abdulrahman

College of Medicine, University of Zakho, Zakho, Kurdistan region, Iraq

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Flichman DM, Blejer JL, Livellara BI, Re VE, Bartoli S, ...
  • Zaheer H, Saeed U, Waheed Y, Karimi S, Waheed U. ...
  • Walter SR, Thein H-H, Amin J, Gidding HF, Ward K, ...
  • Afzal MS, Ahmed T, Zaidi NuSS. Comparison of HCV Prevalence ...
  • Kafi-Abad SA, Rezvan H, Abolghasemi H. Trends in prevalence of ...
  • Hussein NR, Haj SM, Almizori LA, Taha AA. The Prevalence ...
  • Karkar A. Hepatitis C in dialysis units: The Saudi experience. ...
  • Yakaryilmaz F, Alp Gurbuz O, Guliter S, Mert A, Songur ...
  • Ghorbani NR, Djalalinia S, Modirian M, Abdar ZE, Mansourian M, ...
  • Barril G, Traver JA. Decrease in the hepatitis C virus ...
  • Gallego E, López A, Pérez J, Llamas F, Lorenzo I, ...
  • Ibrahim NM, Saleem ZSM, Hussein NR. The Prevalence of HIV, ...
  • Te HS, Jensen DM. Epidemiology of Hepatitis B and C ...
  • Legrand-Abravanel F, Colson P, Leguillou-Guillemette H, Alric L, Ravaux I, ...
  • Al-Kubaisy W, Al-Naib K, Habib M. Seroprevalence of hepatitis C ...
  • Hussein NR, Tunjel I, Basharat Z, Taha A, Irving W. ...
  • Hussein NR. The efficacy and safety of Sofosbuvir-containing regimen in ...
  • Hussein NR, Saleema ZS, Abd QH. Direct Acting Antiviral Treatment ...
  • Koshy A, Madda JP, Marcellin P, Martinot M. Treatment of ...
  • Ohno T, Mizokami M, Saleh MG, Orito E, Ohba KI, ...
  • Zein NN. Clinical significance of hepatitis C virus genotypes. Clin ...
  • نمایش کامل مراجع